Skip to main content
mel-poole-TocLTCixeAw-unsplash-1

Insights

Immunology September 12, 2019

RNA, in a circle, without a label, can rev immune system, new research suggests

By Krista Conger

Mammalian cells use a label to distinguish self from non-self circular RNA molecules. Foreign molecules can trigger anti-cancer immune responses.

It's always fun to be able to provide an update to a previous post. In 2017 I wrote about some intriguing research from the laboratory of dermatologist and genome scientist Howard Chang, MD, PhD, that showed that circular RNA molecules play an important and previously unanticipated role in protecting cells from infection by viruses. These circular RNAs are formed when the intervening bits of a messenger RNA (which carries instructions to make proteins) are removed to leave only the coding parts of a gene.

As Chang explained in an email:

Cells are bombarded by outside invaders, and they have evolved sophisticated systems to tell self and foreign nucleic acids apart. Circular RNAs are a recently recognized class of RNAs that is made by human cells, but some viruses also come as circular RNAs. CircRNAs are of particular interest because they seem far more stable than linear RNAs and last for a long time in the body. My lab discovered that human and mouse cells can distinguish foreign and self circular RNAs, and mount a vigorous immune response against the foreign circRNA.

Now Chang and former postdoctoral scholar Ye Grace Chen, PhD, have learned that the cells rely on a chemical tag appended to the RNA that serves as a kind of authenticity label that differentiates true cellular RNAs from viral knockoffs. They published their findings recently in Molecular Cell.

As Chang explained:

It turns out that when human cells make circular RNAs, those circular RNAs are tagged with a chemical mark which tells the cell that this is "self" and prevents the innate immune system from reacting to it.

Chang and Chen found that, by adding the telltale label, they could help foreign-made RNAs evade the immune system— an advance that could help researchers modulate gene expression in living cells. Conversely, injecting mice with unlabeled circular RNAs amped up the immune response to an anti-tumor vaccine and extended the lifespan of tumor bearing animals.

"I was surprised by the potency of the anti-tumor activity," said Chang. "I thought maybe we'd have to tinker with the system quite a bit to see any effect, but the effect was clear from the beginning."

Now the researchers are doing a deep dive to better understand the molecules' effects on mammalian cell biology.

"Our work so far taught us that the topology of the RNA — its circular shape — can directly communicate with the immune system," Chang said. "Now we're curious about whether and how the specific sequences within these circular RNAs provide other new kinds of instruction for the cell." 

Somehow I have a feeling this particular topic will be rolling around to this blog again someday soon...

Photo by

About Stanford Medicine

Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.

Krista-Conger

Science writer

Krista Conger

Senior science writer Krista Conger, PhD ’99, covers cancer, stem cells, dermatology, developmental biology, endocrinology, pathology, hematology, radiation oncology and LGBTQ+ issues for the office. She received her undergraduate degree in biochemistry at the University of California, Berkeley and her PhD in cancer biology from Stanford University. After completing the science writing program at UC Santa Cruz, she joined the Stanford Medicine Office of Communications in 2000. She enjoys distilling complicated scientific topics into engaging prose accessible to the layperson. Over the years, she has had chronicled nascent scientific discoveries from their inception to Food and Drug Administration approval and routine clinical use — documenting the wonder and long arc of medical research. Her writing has repeatedly been recognized with awards from the Counsel for the Advancement and Support of Education and the Association of American Medical Colleges. She is a member of the National Academy of Science Writers and a certified science editor through the Board of Editors in the Life Sciences. In her spare time, she enjoys textile arts, experimenting with new recipes and hiking in beautiful northwestern Montana, where she was raised and now lives.